Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
Samuel M. Cohen, Richard W. Tsien, Donald Goff, et al.
Schizophrenia Research (2015) Vol. 167, Iss. 1-3, pp. 98-107
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon, John H. Krystal, Oliver Howes
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 15-33
Open Access | Times Cited: 446
Gut Microbiota and the Neuroendocrine System
Aitak Farzi, Esther E. Fröhlich, Peter Holzer
Neurotherapeutics (2018) Vol. 15, Iss. 1, pp. 5-22
Open Access | Times Cited: 388
The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa, Kiran Sapkota
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107426-107426
Open Access | Times Cited: 226
Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
Tapan Behl, Dapinder Kaur, Aayush Sehgal, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3724-3724
Open Access | Times Cited: 206
The Gut-Brain Axis, BDNF, NMDA and CNS Disorders
R Maqsood, Trevor W. Stone
Neurochemical Research (2016) Vol. 41, Iss. 11, pp. 2819-2835
Open Access | Times Cited: 192
Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications
Zhen Yan, Benjamin Rein
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 445-465
Open Access | Times Cited: 189
Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization
Hengyi Cao, Oliver Y. Chén, Yoonho Chung, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 187
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Аnna Morozova, Yana Zorkina, Olga Abramova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 69
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 53
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
Holger Rosenbrock, Michael Desch, Glen Wunderlich
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1557-1566
Open Access | Times Cited: 43
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 40
Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical Circuits
Roberta Tatti, Melissa S. Haley, Olivia K. Swanson, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 10, pp. 821-831
Open Access | Times Cited: 166
NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
Daniela Cadinu, B. Terence Grayson, Giovanni Podda, et al.
Neuropharmacology (2017) Vol. 142, pp. 41-62
Open Access | Times Cited: 142
Aberrant Network Activity in Schizophrenia
Mark J. Hunt, Nancy Kopell, Roger D. Traub, et al.
Trends in Neurosciences (2017) Vol. 40, Iss. 6, pp. 371-382
Open Access | Times Cited: 106
Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
Alexei M. Bygrave, Simonas Masiulis, Elizabeth Nicholson, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 4, pp. e778-e778
Open Access | Times Cited: 104
GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies
Chiara Chiapponi, Federica Piras, Fabrizio Piras, et al.
Frontiers in Psychiatry (2016) Vol. 7
Open Access | Times Cited: 100
Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans
Sara de la Salle, Joëlle Choueiry, Dhrasti Shah, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 100
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
Kazu Nakazawa, Vivek Jeevakumar, Kazuhito Nakao
Schizophrenia (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 98
Excitation-Transcription Coupling in Parvalbumin-Positive Interneurons Employs a Novel CaM Kinase-Dependent Pathway Distinct from Excitatory Neurons
Samuel M. Cohen, Huan Ma, Kishore V. Kuchibhotla, et al.
Neuron (2016) Vol. 90, Iss. 2, pp. 292-307
Open Access | Times Cited: 95
7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings
Katharine N. Thakkar, Lara Rösler, Jannie P. Wijnen, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 6, pp. 525-535
Closed Access | Times Cited: 88
Tonic Activation of GluN2C/GluN2D-Containing NMDA Receptors by Ambient Glutamate Facilitates Cortical Interneuron Maturation
Elizabeth Hanson, Moritz Armbruster, Lauren A. Lau, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 19, pp. 3611-3626
Open Access | Times Cited: 83
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Melissa A. Snyder, Wen‐Jun Gao
Schizophrenia Research (2019) Vol. 217, pp. 60-70
Open Access | Times Cited: 78
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6460-6501
Open Access | Times Cited: 54
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
August P. M. Lullau, E. Haga, Eivind Haga Ronold, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top